Event

Pharma Congress 

TDI was proud to be a silver sponsor of this year’s Pharmaceutical and Medical Device Ethics and Compliance Congress in Washington, DC, where David Fisher moderated a panel: “Beyond the Questionnaire: Building a Risk-Based Third-Party Management Program That Actually Works.”

Three key takeaways for life sciences companies navigating increasingly complex third-party relationships:

1. Risk is dynamic. Ownership changes and hidden relationships can introduce new risks long after onboarding.

2. Risk-based oversight matters. Effective risk-tiering helps organizations focus due diligence and monitoring where exposure is greatest.

3. Technology needs human intelligence. AI-driven screening and continuous monitoring can identify emerging risks, but human expertise remains essential to uncover hidden connections and inform decisions.

Thank you to everyone who stopped by the TDI booth to connect with our team.

img-event

Date: October 13-16, 2026

Location: Washington, DC

View More Events

img-featured

Consero’s Energy General Counsel Forum

View
img-featured

Global Investigations Summit

View
img-featured

Consero’s Life Sciences General Counsel Forum

View